Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

Clinical trial NCT02667743 · UNKNOWN

Trial details

NCT number: NCT02667743
Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer(NSCLC)

Start date: 2015-05-01
Primary completion: 2019-01-01
Enrollment: 454

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.